Patient Square Capital »

Belite Bio shares owned by Patient Square Capital

Quarter-by-quarter ownership of Belite Bio (BLTE) shares owned by Patient Square Capital from 13F filings

Historical chart of Patient Square Capital investment in Belite Bio

Tip: Access up to 7 years of quarterly data

All positions including Belite Bio held by Patient Square Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Belite Bio by Patient Square Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $19M 117k 159.44

More positions owned by Patient Square Capital

Roivant Sciences SHS (ROIV)
Argenx Se Sponsored Adr (ARGX)
Insmed Com Par $.01 (INSM)
Beone Medicines Sponsored Ads (ONC)
Cogent Biosciences (COGT)
Mirum Pharmaceuticals (MIRM)
Belite Bio Sponsored Ads (BLTE)
Legend Biotech Corp Sponsored Ads (LEGN)
Nektar Therapeutics Com New (NKTR)
Dbv Technologies S A Sponsored Ads (DBVT)
Pharvaris N V (PHVS)
Abivax Sa Sponsored Ads (ABVX)
Xenon Pharmaceuticals (XENE)
Celcuity (CELC)
Eyepoint Com New (EYPT)

View all positions for Patient Square Capital

Top funds holding Belite Bio

Darwin Global Management
Paradigm Biocapital Advisors
UBS Group
Rtw Investments
Millennium Management
Holocene Advisors
Eventide Asset Management
Deerfield Management Company
Morgan Stanley
Marshall Wace
Perceptive Advisors
Patient Square Capital
Duquesne Family Office
Goldman Sachs Group
MPM Oncology Impact Management

View all funds holding Belite Bio